Skip to main content

EMERSON ELECTRIC CO

For the period ended Mar 31, 2024. Filed May 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 8, 2024

EMR$162.35-0.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Item 1. Financial Statements

(Dollars in millions, except per share amounts; unaudited)

Three Months EndedMarch 31,Six Months EndedMarch 31,
2023202420232024
Net sales$3,7564,376$7,1298,493
Cost of sales1,9552,0923,7084,293
Selling, general and administrative expenses1,0001,2962,0302,573
Gain on subordinated interest—(79)—(79)
Other deductions, net109389229876
Interest expense (net of interest income of $18, $33, $38 and $73, respectively)5357101101
Interest income from related party—(31)—(62)
Earnings from continuing operations before income taxes6396521,061791
Income taxes134149232156
Earnings from continuing operations505503829635
Discontinued operations, net of tax of $39, $—, $1,005 and $—, respectively265—2,267—
Net earnings7705033,096635
Less: Noncontrolling interests in subsidiaries(22)2(27)(8)
Net earnings common stockholders$792501$3,123643
Earnings common stockholders:
Earnings from continuing operations530501$859643
Discontinued operations262—2,264—
Net earnings common stockholders$792501$3,123643
Basic earnings per share common stockholders:
Earnings from continuing operations$0.930.87$1.491.12
Discontinued operations0.46—3.92—
Basic earnings per common share$1.390.87$5.411.12
Diluted earnings per share common stockholders:
Earnings from continuing operations$0.920.87$1.481.12
Discontinued operations0.46—3.90—
Diluted earnings per common share$1.380.87$5.381.12
Weighted average outstanding shares:
Basic570.9571.4577.2571.1
Diluted573.6574.1580.1573.7

Consolidated Statements of Comprehensive Income

Three Months Ended March 31,Six Months Ended March 31,
2023202420232024
Net earnings$770503$3,096635
Other comprehensive income (loss), net of tax:
Foreign currency translation1106351180
Pension and postretirement(17)(12)(33)(24)
Cash flow hedges13(1)232
Total other comprehensive income (loss)106(7)341158
Comprehensive income8764963,437793
Less: Noncontrolling interests in subsidiaries(23)2(23)(6)
Comprehensive income common stockholders$899494$3,460799

Consolidated Balance Sheets

(Dollars and shares in millions, except per share amounts; unaudited)

Sept 30, 2023Mar 31, 2024
ASSETS
Current assets
Cash and equivalents$8,0512,318
Receivables, less allowances of $100 and $117, respectively2,5182,877
Inventories2,0062,357
Other current assets1,2441,457
Total current assets13,8199,009
Property, plant and equipment, net2,3632,689
Other assets
Goodwill14,48017,964
Other intangible assets6,26310,976
Copeland note receivable and equity investment3,2553,191
Other2,5662,611
Total other assets26,56434,742
Total assets$42,74646,440
LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and current maturities of long-term debt$5473,155
Accounts payable1,2751,271
Accrued expenses3,2103,238
Total current liabilities5,0327,664
Long-term debt7,6107,614
Other liabilities3,5064,381
Equity
Common stock, $0.50 par value; authorized, 1,200.0 shares; issued, 953.4 shares; outstanding, 572.0 shares and 572.1 shares, respectively477477
Additional paid-in-capital62158
Retained earnings40,07040,108
Accumulated other comprehensive income (loss)(1,253)(1,097)
Cost of common stock in treasury, 381.4 shares and 381.3 shares, respectively(18,667)(18,746)
Common stockholders’ equity20,68920,900
Noncontrolling interests in subsidiaries5,9095,881
Total equity26,59826,781
Total liabilities and equity$42,74646,440

Consolidated Statements of Equity

Three Months Ended March 31,Six Months Ended March 31,
2023202420232024
Common stock$477477477477
Additional paid-in-capital
Beginning balance1121405762
Stock plans265181170
AspenTech purchases of common stock—(33)—(74)
Ending balance138158138158
Retained earnings
Beginning balance30,07639,91028,05340,070
Net earnings common stockholders7925013,123643
Dividends paid (per share: $0.520, $0.525, $1.040 and $1.050, respectively)(297)(303)(605)(605)
Ending balance30,57140,10830,57140,108
Accumulated other comprehensive income (loss)
Beginning balance(1,255)(1,090)(1,485)(1,253)
Foreign currency translation1116347178
Pension and postretirement(17)(12)(33)(24)
Cash flow hedges13(1)232
Ending balance(1,148)(1,097)(1,148)(1,097)
Treasury stock
Beginning balance(18,683)(18,763)(16,738)(18,667)
Purchases——(2,000)(175)
Issued under stock plans5176096
Ending balance(18,678)(18,746)(18,678)(18,746)
Common stockholders' equity11,36020,90011,36020,900
Noncontrolling interests in subsidiaries
Beginning balance5,9875,8815,9525,909
Net earnings (loss)(22)2(27)(8)
Stock plans23225833
AspenTech purchases of common stock—(24)—(55)
Other comprehensive income(1)—42
Ending balance5,9875,8815,9875,881
Total equity$17,34726,78117,34726,781

Consolidated Statements of Cash Flows

Six Months Ended March 31, 2023 and 2024

Six Months Ended
March 31,
20232024
Operating activities
Net earnings$3,096635
Earnings from discontinued operations, net of tax(2,267)—
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization523846
Stock compensation142147
Amortization of acquisition-related inventory step-up—231
Gain on subordinated interest—(79)
Changes in operating working capital(390)(373)
Other, net(227)(206)
Cash from continuing operations8771,201
Cash from discontinued operations(391)(43)
Cash provided by operating activities4861,158
Investing activities
Capital expenditures(121)(159)
Purchases of businesses, net of cash and equivalents acquired—(8,342)
Proceeds from subordinated interest1579
Other, net(76)(68)
Cash from continuing operations(182)(8,490)
Cash from discontinued operations2,9161
Cash provided by (used in) investing activities2,734(8,489)
Financing activities
Net increase (decrease) in short-term borrowings(31)2,464
Proceeds from short-term borrowings greater than three months39599
Payments of long-term debt(742)(1)
Dividends paid(603)(600)
Purchases of common stock(2,000)(175)
AspenTech purchases of common stock—(129)
Other, net(55)(45)
Cash provided by (used in) financing activities(3,036)1,613
Effect of exchange rate changes on cash and equivalents58(15)
Increase (decrease) in cash and equivalents242(5,733)
Beginning cash and equivalents1,8048,051
Ending cash and equivalents$2,0462,318
Changes in operating working capital
Receivables$(63)(35)
Inventories(219)(46)
Other current assets22(69)
Accounts payable(98)(46)
Accrued expenses(32)(177)
Total changes in operating working capital$(390)(373)

Notes to Consolidated Financial Statements

(Dollars and shares in millions, except per share amounts or where noted)

(1)BASIS OF PRESENTATION

In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments necessary for a fair presentation of operating results for the interim periods presented. Adjustments consist of normal and recurring accruals. The consolidated financial statements are presented in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required for annual financial statements presented in conformity with U.S. generally accepted accounting principles (GAAP). For further information, refer to the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended September 30, 2023.

(2)REVENUE RECOGNITION

Emerson is a global manufacturer that designs and manufactures products and delivers services that bring technology and engineering together to provide innovative solutions for its customers. The majority of the Company's revenues relate to a broad offering of manufactured products and software which are recognized at the point in time when control transfers, while a smaller portion is recognized over time or relates to sales arrangements with multiple performance obligations. See Note 14 for additional information about the Company's revenues.

The following table summarizes the balances of the Company's unbilled receivables (contract assets), which are reported in Other assets (current and noncurrent), and its customer advances (contract liabilities), which are reported in Accrued expenses and Other liabilities.

Sept 30, 2023Mar 31, 2024
Unbilled receivables (contract assets)$1,4531,480
Customer advances (contract liabilities)(897)(1,187)
Net contract assets (liabilities)$556293

The majority of the Company's contract balances relate to (1) arrangements where revenue is recognized over time and payments from customers are made according to a contractual billing schedule, and (2) revenue from term software license arrangements where the license revenue is recognized upfront upon delivery. The decrease in net contract assets was primarily due to the acquisition of National Instruments, which increased contract liabilities by approximately $190, while customer billings slightly exceeded revenue recognized for performance completed during the period. Revenue recognized for the three and six months ended March 31, 2024 included $154 and $522, respectively, that was included in the beginning contract liability balance. Other factors that impacted the change in net contract assets were immaterial. Revenue recognized for the three and six months ended March 31, 2024 for performance obligations that were satisfied in previous periods, including cumulative catchup adjustments on the Company's long-term contracts, was immaterial.

As of March 31, 2024, the Company's backlog relating to unsatisfied (or partially unsatisfied) performance obligations in contracts with its customers was approximately $8.8 billion (of which approximately $1.25 billion was attributable to AspenTech and approximately $500 was attributable to National Instruments). The Company expects to recognize appro ximately 75 percent of its remaining performance obligations as revenue over the next 12 months, with the remainder substantially over the following two years.

(3)COMMON SHARES

Reconciliations of weighted-average shares for basic and diluted earnings per common share follow. Earnings allocated to participating securities were inconsequential.

Three Months EndedMarch 31,Six Months EndedMarch 31,
2023202420232024
Basic shares outstanding570.9571.4577.2571.1
Dilutive shares2.72.72.92.6
Diluted shares outstanding573.6574.1580.1573.7

(4)ACQUISITIONS AND DIVESTITURES

National Instruments

On October 11, 2023, the Company completed the acquisition of National Instruments Corporation (“NI”). NI, which provides software-connected automated test and measurement systems that enable enterprises to bring products to market faster and at a lower cost, had revenues of approximately $1.7 billion and pretax earnings of approximately $170 for the 12 months ended September 30, 2023. NI is now referred to as Test & Measurement and reported as a new segment in the Software and Control business group, see Note 14.

The following table summarizes the components of the purchase consideration reflected in the acquisition accounting for NI.

Cash paid to acquire remaining NI shares not already owned by Emerson$7,833
Payoff of NI debt at closing634
Total consideration paid in cash at closing8,467
Fair value of NI shares already owned by Emerson prior to acquisition137
Value of stock-based compensation awards attributable to pre-combination service49
Total purchase consideration$8,653

The total purchase consideration for NI was allocated to assets and liabilities as follows. Valuations of acquired assets and liabilities are in-process and subject to refinement.

Cash and equivalents$135
Receivables310
Inventory514
Other current assets139
Property, plant and equipment328
Goodwill ($130 expected to be tax-deductible)3,407
Other intangible assets5,275
Other assets120
Total assets10,228
Accounts payable52
Accrued expenses326
Deferred taxes and other liabilities1,197
Total purchase consideration$8,653

The estimated intangible assets attributable to the transaction are comprised of the following(in millions):

AmountEstimated Weighted Average Life (Years)
Developed technology$1,5709
Customer relationships3,36015
Trade names2109
Backlog1351
Total$5,275

Results of operations for the three and six months ended March 31, 2024 attributable to the NI acquisition include sales of $367 and $749, respectively, and a net loss of $80 and $406, respectively. The net loss included the impact of inventory step-up amortization recorded in the first quarter, intangibles amortization, retention bonuses, stock compensation expense and restructuring.

Pro Forma Financial Information

The following unaudited proforma consolidated condensed financial results of operations are presented as if the acquisition of NI occurred on October 1, 2022. The pro forma information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved had the acquisition occurred as of that time ($ in millions, except per share amounts).

Three Months Ended March 31,Six Months Ended March 31,
2023202420232024
Net Sales$4,1934,376$8,0148,512
Net earnings from continuing operations common stockholders$447530$306950
Diluted earnings per share from continuing operations$0.770.92$0.531.65

Pro forma Net sales for the three and six months ended March 31, 2023 include $437 and $885, respectively, attributable to NI.

The pro forma results for the three months ended March 31, 2023 include ongoing intangibles amortization of $107 and backlog amortization of $34, and exclude the mark-to-market gain of $35 recognized in the prior year on the Company's equity investment in National Instruments Corporation (see Note 7).

The pro forma results for the six months ended March 31, 2023 include transaction costs of $198 which were assumed to be incurred in the first quarter of fiscal 2023. These transaction costs include $88 incurred by NI prior to the completion of the transaction and $110 incurred by Emerson in periods subsequent to the first quarter of fiscal 2023. The pro forma results for the six months ended March 31, 2023 also include $212 of ongoing intangibles amortization, backlog amortization of $68, inventory step-up amortization of $213, and retention bonuses of $47, and exclude the mark-to-market gain of $35 recognized in the prior year on the equity investment in National Instruments Corporation.

Other Transactions

In the second quarter of fiscal 2024, the Company received its final distribution of $79 related to its subordinated interest in Vertiv. In addition, the Company divested a small business in the Final Control segment and recognized a non-cash loss of $39.

In the fourth quarter of fiscal 2023, the Company acquiredtwo businesses, Flexim, which is reported in the Measurement & Analytical segment, and Afag, which is reported in the Discrete Automation segment, for $715, net of cash acquired. The Company recognized goodwill of $423 (none of which is expected to be tax deductible) and other identifiable intangible assets of $323, primarily customer relationships and intellectual property with a weighted-average useful life of approximately 9 years.

On March 31, 2023, Emerson completed the divestiture of Metran, its Russia-based manufacturing subsidiary. In the first quarter of fiscal 2023, the Company recognized a pretax loss of $47 in Other deductions ($47 after-tax, in total$0.08 per share) related to its exit of business operations in Russia.

(5)DISCONTINUED OPERATIONS

On May 31, 2023, the Company completed the sale of a majority stake in its Climate Technologies business (which constitutes the former Climate Technologies segment, excluding Therm-O-Disc which was divested earlier in fiscal 2022) to private equity funds managed by Blackstone in a $14.0 billion transaction. Emerson received upfront, pre-tax cash proceeds of approximately $9.7 billion and a note receivable with a face value of $2.25 billion (which accrues 5 percent interest payable in kind by capitalizing interest), while retaining a 40 percent non-controlling common equity interest in a new standalone joint venture between Emerson and Blackstone. The Climate Technologies business, which includes the Copeland compressor business and the entire portfolio of products and services across all residential and commercial HVAC and refrigeration end-markets, had fiscal 2022 net sales of approximately $5.0 billion and pretax earnings of $1.0 billion. The Company recognized a pretax gain of approximately $10.6 billion in the third quarter of fiscal 2023 (approximately $8.4 billion after-tax including tax expense recognized prior to the completion of the transaction related to subsidiary restructurings). The new standalone business is named Copeland. See Note 10 for further details.

On October 31, 2022, the Company completed the divestiture of its InSinkErator business, which manufactures food waste disposers, to Whirlpool Corporation for $3.0 billion. This business had net sales of $630 and pretax earnings of $152 in fiscal 2022. The Company recognized a pretax gain of approximately $2.8 billion (approximately $2.1 billion after-tax) in the first quarter of fiscal 2023.

The financial results of Climate Technologies and InSinkErator ("ISE") are reported as discontinued operations for the three and six months ended March 31, 2023 and were as follows:

Three Months Ended March 31, 2023
Climate TechnologiesISETotal
Net sales$1,245—1,245
Cost of sales782—782
SG&A127—127
Gain on sale of business—(3)(3)
Other deductions, net35—35
Earnings before income taxes3013304
Income taxes39—39
Earnings, net of tax$2623265
Six Months Ended March 31, 2023
Climate TechnologiesISETotal
Net sales$2,309492,358
Cost of sales1,484291,513
SG&A2698277
Gain on sale of business—(2,783)(2,783)
Other deductions, net671279
Earnings before income taxes4892,7833,272
Income taxes3526531,005
Earnings, net of tax$1372,1302,267

Climate Technologies' results for the three and six months ended March 31, 2023 included lower expense of $43 and $70, respectively, due to ceasing depreciation and amortization upon the held-for-sale classification. Other deductions, net for Climate Technologies included $28 and $55 of transaction-related costs for the three and six months ended March 31, 2023, respectively. Income taxes for the six months ended March 31, 2023 included approximately $245 for Climate Technologies subsidiary restructurings and approximately $660 related to the gain on the InSinkErator divestiture.

Net cash from operating and investing activities for Climate Technologies, InSinkErator and Therm-O-Disc for the six months ended March 31, 2024 and 2023 were as follows:

Climate Technologies · ISE and TOD · Total
Six Months Ended March 31,Six Months Ended March 31,Six Months Ended March 31,
202320242023202420232024
Cash from operating activities$44(43)(435)—(391)(43)
Cash from investing activities$(139)13,055—2,9161

Cash from operating activities for the six months ended March 31, 2023 reflects approximately $575 of income taxes paid related to the gain on the InSinkErator divestiture and the Climate Technologies subsidiary restructurings, transaction fees and unfavorable working capital. Cash from investing activities for the six months ended March 31, 2023 reflects the proceeds of $3.0 billion related to the InSinkErator divestiture.

(6)PENSION & POSTRETIREMENT PLANS

Total periodic pension and postretirement (income) expense is summarized below:

Three Months Ended March 31,Six Months Ended March 31,
2023202420232024
Service cost$129$2418
Interest cost5455108110
Expected return on plan assets(71)(74)(142)(148)
Net amortization(20)(14)(40)(28)
Total$(25)(24)$(50)(48)

(7)OTHER DEDUCTIONS, NET

Other deductions, net are summarized below:

Three Months EndedMarch 31,Six Months EndedMarch 31,
2023202420232024
Amortization of intangibles (intellectual property and customer relationships)$119273237547
Restructuring costs193029113
Acquisition/divestiture costs1051085
Foreign currency transaction (gains) losses26171951
Investment-related gains & gains from sales of capital assets(35)—(39)—
Loss on Copeland equity method investment—59—95
Loss on divestiture of business—39—39
Russia business exit——47—
Other(30)(34)(74)(54)
Total$109389229876

Intangibles amortization for the three and six months ended March 31, 2024 included $141 and $280, respectively, related to the NI acquisition. Foreign currency transaction losses for the three and six months ended March 31, 2023 included a mark-to-market loss of $14 and a gain of $21, respectively, related to foreign currency forward contracts that were terminated in June 2023. The Company recognized a mark-to-market gain of $35 for the three months ended March 31, 2023 related to its equity investment in National Instruments Corporation. Other is composed of several items, including a portion of pension expense, litigation costs, provision for bad debt and other items, none of which is individually significant.

(8)RESTRUCTURING COSTS

Restructuring expense reflects costs associated with the Company’s ongoing efforts to improve operational efficiency and deploy assets globally in order to remain competitive on a worldwide basis. The Company expects fiscal 2024 restructuring expense and related costs to be approximately $230, including costs to complete actions initiated in the first six months of the year.

Restructuring expense by business segment follows:

Three Months Ended March 31,Six Months EndedMarch 31,
2023202420232024
Final Control$2(7)1(4)
Measurement & Analytical—114
Discrete Automation77817
Safety & Productivity2121
Intelligent Devices1121218
Control Systems & Software5364
Test & Measurement—14—54
AspenTech————
Software and Control517658
Corporate3111137
Total$193029113

Corporate restructuring of $11 and $37 for the three and six months ended March 31, 2024, respectively, is comprised almost entirely of integration-related stock compensation expense attributable to NI.

Details of the change in the liability for restructuring costs during the six months ended March 31, 2024 follow:

Sept 30, 2023ExpenseUtilized/PaidMar 31, 2024
Severance and benefits$859510080
Other218155
Total$8711311585

The tables above do not include $7 and $3 of costs related to restructuring actions incurred for the three months ended March 31, 2023 and 2024, respectively, that are required to be reported in cost of sales and selling, general and administrative expenses; year-to-date amounts are $12 and $7, respectively.

(9)TAXES

Income taxes were $149 in the second quarter of fiscal 2024 and $134 in 2023, resulting in effective tax rates of 23 percent and 21 percent, respectively. The current year rate was negatively impacted by approximately 2 percentage points due to the loss on divestiture (see Note 4), which was nondeductible for tax purposes.

Income taxes were $156 in the first six of months of fiscal 2024 and $232 in 2023, resulting in effective tax rates of 20 percent and 22 percent, respectively. The current year rate included a $57 ($0.10 per share) benefit related to discrete tax items, partially offset by unfavorable impacts from inventory step-up amortization and the loss on divestiture noted above. In total, the net impact of these items benefited the rate by approximately 1 percentage point.

(10)EQUITY METHOD INVESTMENT AND NOTE RECEIVABLE

As discussed in Note 5, the Company completed the divestiture of a majority stake in Copeland on May 31, 2023, and received upfront, pre-tax cash proceeds of approximately $9.7 billion and a note receivable with a face value of $2.25 billion, while retaining a 40 percent non-controlling common equity interest in Copeland.

The Company records its share of Copeland's income or loss using the equity method of accounting. For the three and six months ended March 31, 2024 the Company recorded a loss of $59 and$95, respectively, in Other deductions to reflect its share of Copeland's losses and a tax benefit of $13 and$22, respectively, in Income taxes related to Copeland's U.S. business, which is taxed as a partnership (in total, a loss of $0.08 and$0.12 per share, respectively). The Company recognized non-cash interest income on the note receivable of $31 and $62 for the three and six months ended March 31, 2024, respectively, which is reported in Interest income from related party and capitalized to the carrying value of the note.

As of March 31, 2024, the carrying values of the retained equity investment and note receivable were $1,036 and $2,155, respectively.

Summarized financial information for Copeland for the three and six months ended March 31, 2024 is as follows.

Three Months Ended March 31,Six Months Ended March 31,
20242024
Net sales$1,175$2,199
Gross profit$412$757
Income (loss) from continuing operations$(147)$(240)
Net income (loss)$(147)$(240)
Net income (loss) attributable to shareholders$(148)$(238)

(11)OTHER FINANCIAL INFORMATION

Sept 30, 2023Mar 31, 2024
Inventories
Finished products$446593
Raw materials and work in process1,5601,764
Total$2,0062,357
Property, plant and equipment, net
Property, plant and equipment, at cost$5,5245,976
Less: Accumulated depreciation3,1613,287
Total$2,3632,689
Goodwill by business segment
Final Control$2,6602,682
Measurement & Analytical1,5451,560
Discrete Automation892908
Safety & Productivity388399
Intelligent Devices5,4855,549
Control Systems & Software668671
Test & Measurement—3,415
AspenTech8,3278,329
Software and Control8,99512,415
Total$14,48017,964
Sept 30, 2023Mar 31, 2024
Other intangible assets
Gross carrying amount$10,11115,484
Less: Accumulated amortization3,8484,508
Net carrying amount$6,26310,976

Other intangible assets include customer relationships, net, of $3,353 and $6,501 and intellectual property, net, of $2,707 and $4,247 as of September 30, 2023 and March 31, 2024, respectively.

The increase in goodwill and intangibles was primarily due to the NI acquisition. See Note 4.

Three Months Ended March 31,Six Months Ended March 31,
2023202420232024
Depreciation and amortization expense include the following:
Depreciation expense$7279146158
Amortization of intangibles (includes $49, $49, $98 and $98 reported in Cost of Sales, respectively)168322335645
Amortization of capitalized software23234243
Total$263424523846

Amortization of intangibles included $141 and $280 related to the NI acquisition for the three and six months ended March 31, 2024.

Sept 30, 2023Mar 31, 2024
Other assets include the following:
Pension assets$9951,053
Operating lease right-of-use assets550686
Unbilled receivables (contract assets)559528
Deferred income taxes10063
Asbestos-related insurance receivables5348
Accrued expenses include the following:
Customer advances (contract liabilities)$8611,100
Employee compensation618531
Income taxes207220
Operating lease liabilities (current)144155
Product warranty8474
Other liabilities include the following:
Deferred income taxes$1,9592,654
Operating lease liabilities (noncurrent)404511
Pension and postretirement liabilities435447
Asbestos litigation173164

The increase in deferred income tax liabilities reflects the impact of the NI acquisition. See Note 4.

(12)FINANCIAL INSTRUMENTS

Hedging Activities – As of March 31, 2024, the notional amount of foreign currency hedge positions was approximately $3.2 billion. All derivatives receiving hedge accounting are cash flow hedges. The majority of hedging gains and losses deferred as of March 31, 2024 are expected to be recognized over the next 12 months as the underlying forecasted transactions occur. Gains and losses on foreign currency derivatives reported in Other deductions, net reflect hedges of balance sheet exposures that do not receive hedge accounting.

Net Investment Hedge– In fiscal 2019, the Company issued euro-denominated debt of €1.5 billion. The euro notes reduce foreign currency risk associated with the Company's international subsidiaries that use the euro as their functional currency and have been designated as a hedge of a portion of the investment in these operations. Foreign currency gains or losses associated with the euro-denominated debt are deferred in accumulated other comprehensive income (loss) and will remain until the hedged investment is sold or substantially liquidated.

The following gains and losses are included in earnings and other comprehensive income (OCI) for the three and six months ended March 31, 2023 and 2024:

Into Earnings · Into OCI
2nd Quarter · Six Months · 2nd Quarter · Six Months
Gains (Losses) · Location · 2023 · 2024 · 2023 · 2024 · 2023 · 2024 · 2023 · 2024
CommodityCost of sales$(2)—(10)—8—19—
Foreign currencySales(1)—(2)—(1)(5)32
Foreign currencyCost of sales103186176147
Foreign currencyOther deductions, net(22)(26)(17)(11)
Net Investment Hedges
Euro denominated debt——(14)3(137)(52)
Total$(15)(23)(11)(5)104(101)(43)

Regardless of whether derivatives and non-derivative financial instruments receive hedge accounting, the Company expects hedging gains or losses to be offset by losses or gains on the related underlying exposures. The amounts ultimately recognized will differ from those presented above for open positions, which remain subject to ongoing market price fluctuations until settlement. Derivatives receiving hedge accounting are highly effective and no amounts were excluded from the assessment of hedge effectiveness.

Fair Value Measurement – Valuations for all derivatives, the Company's note receivable from Copeland, and the Company's long-term debt fall within Level 2 of the GAAP valuation hierarchy. The fair value of the note receivable as of March 31, 2024 was approximately $2.0 billion, which was lower than the carrying value by approximately $100. See Note 10 for further details. As of March 31, 2024, the fair value of long-term debt was approximately $7.2 billion, which was lower than the carrying value by $963. The fair value of foreign currency contracts, which are reported in Other current assets and Accrued expenses, did not materially change since September 30, 2023. Commodity contracts related to discontinued operations and were novated to Copeland upon the completion of the transaction.

Counterparties to derivatives arran gements are companies with investment-grade credit ratings. The Company has bilateral collateral arrangements with counterparties with credit rating-based posting thresholds that vary depending on the arrangement. If credit ratings on the Company's debt fall below pre-established levels, counterparties can require immediate full collateralization of all derivatives in net liability positions. The maximum amount that could potentially have been required was immaterial. The Company also can demand full collateralization of derivatives in net asset positions should any counterparty credit ratings fall below certain thresholds. No collateral was posted with counterparties andnone was held by the Company as of March 31, 2024.

(13)ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Activity in Accumulated other comprehensive income (loss) for the three and six months ended March 31, 2023 and 2024 is shown below, net of income taxes:
Three Months Ended March 31,Six Months Ended March 31,
2023202420232024
Foreign currency translation
Beginning balance$(1,029)(840)(1,265)(1,012)
Other comprehensive income (loss), net of tax of $4, $(1), $32 and $12, respectively111(17)347155
Reclassification to loss on divestiture of business—23—23
Ending balance(918)(834)(918)(834)
Pension and postretirement
Beginning balance(238)(259)(222)(247)
Amortization of deferred actuarial losses into earnings, net of tax of $3, $2, $7 and $4, respectively(17)(12)(33)(24)
Ending balance(255)(271)(255)(271)
Cash flow hedges
Beginning balance12926
Gains deferred during the period, net of taxes of $(6), $0, $(9) and $(2), respectively181277
Reclassification of realized (gains) losses to sales and cost of sales, net of tax of $2, $1, $2 and $1, respectively(5)(2)(4)(5)
Ending balance258258
Accumulated other comprehensive income (loss)$(1,148)(1,097)(1,148)(1,097)

(14)BUSINESS SEGMENTS

As disclosed in Note 4, the Company completed the acquisition of NI on October 11, 2023. NI is now referred to as Test & Measurement and reported as a new segment in the Software and Control business group.

Summarized information about the Company's results of operations by business segment follows:

Three Months Ended March 31, · Six Months Ended March 31,
Sales · Earnings (Loss) · Sales · Earnings (Loss)
2023 · 2024 · 2023 · 2024 · 2023 · 2024 · 2023 · 2024
Final Control$9921,0512152591,8541,991373453
Measurement & Analytical8881,0132292741,6371,960404509
Discrete Automation6836321331161,3011,245254213
Safety & Productivity3613658383671687146151
Intelligent Devices2,9243,0616607325,4635,8831,1771,326
Control Systems & Software6236871271511,2291,362234300
Test & Measurement—367—(79)—749—(157)
AspenTech230278(54)(8)473535(87)(43)
Software and Control8531,33273641,7022,646147100
Stock compensation(40)(73)(142)(147)
Unallocated pension and postretirement costs46389169
Corporate and other(47)(103)(111)(502)
Loss on Copeland equity method investment—(59)—(95)
Gain on subordinated interest—79—79
Eliminations/Interest(21)(17)(53)(57)(36)(36)(101)(101)
Interest income from related party—31—62
Total$3,7564,3766396527,1298,4931,061791

Stock compensation for the three months and six months ended March 31, 2024 included $14 and $44 of integration-related stock compensation expense attributable to NI (of which $10 and $36, respectively, was reported as restructuring costs). Corporate and other for the three and six months ended March 31, 2024 included acquisition/divestiture fees and related costs of $16 and $146, respectively, anda divestiture loss of $39, while year-to-date also includes acquisition-related inventory step-up amortization of $231. Corporate and other for the six months ended March 31, 2023 included a loss of $47 related to the Company's exit of business operations in Russia and a mark-to-market gain of $35 related to its equity investment in National Instruments Corporation.

Depreciation and amortization (includes intellectual property, customer relationships and capitalized software) by business segment are summarized below:

Three Months Ended March 31,Six Months Ended March 31,
2023202420232024
Final Control$45399079
Measurement & Analytical28335873
Discrete Automation22214343
Safety & Productivity15152929
Intelligent Devices110108220224
Control Systems & Software24284549
Test & Measurement—153—304
AspenTech123124246247
Software and Control147305291600
Corporate and other6111222
Total$263424523846

Test & Measurement depreciation and amortization for the three and six months ended March 31, 2024 included intangibles amortization of $141 and $280 due to the acquisition.

Sales by geographic destination, Americas, Asia, Middle East & Africa ("AMEA") and Europe, are summarized below:

Three Months Ended March 31, · Three Months Ended March 31,
20232024
AmericasAMEAEuropeTotalAmericasAMEAEuropeTotal
Final Control$4943621369925134041341,051
Measurement & Analytical4553041298885123341671,013
Discrete Automation311184188683294161177632
Safety & Productivity27216733612691977365
Intelligent Devices1,5328665262,9241,5889185553,061
Control Systems & Software314186123623321217149687
Test & Measurement————16298107367
AspenTech11461552301217384278
Software and Control4282471788536043883401,332
Total$1,9601,1137043,7772,1921,3068954,393
Six Months Ended March 31, · Six Months Ended March 31,
20232024
AmericasAMEAEuropeTotalAmericasAMEAEuropeTotal
Final Control$9406702441,8549677742501,991
Measurement & Analytical8515502361,6379876593141,960
Discrete Automation6023593401,3015803233421,245
Safety & Productivity5083313067151235140687
Intelligent Devices2,9011,6129505,4633,0461,7911,0465,883
Control Systems & Software6083712501,2296464262901,362
Test & Measurement————326197226749
AspenTech226124123473261133141535
Software and Control8344953731,7021,2337566572,646
Corporate and other
Total$3,7352,1071,3237,1654,2792,5471,7038,529

Items 2 and 3.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.